
|Articles|June 1, 2003
Bimatoprost effective in patients with POAG, hypertension
Author(s)Chet Scerra
Fort Lauderdale, FL-Bimatoprost appears to have greater IOP-lowering effectiveness than travoprost in patients with primary open-angle glaucoma (POAG) or ocular hypertension, according to a small pilot study.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
2
Glaucoma innovation: Eight themes to watch in 2026
3
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
4
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
5












































